Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DG-051 in patients with prior myocardial infarction
2007-004913-32Phase 2Terminated
- Sponsor
- deCODE genetics ehf.
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in myocardial infarction (MI) and cardiac morbidity comparing DG-051 with Placebo (2 arms). Primary endpoint: Safety and tolerability of DG-051. Started Feb 2008; status: terminated.
02
Drugs
DG051
03
Conditions
myocardial infarction (MI)cardiac morbidity
Beyond the preview
Go deeper on 2007-004913-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004913-32.